false
--12-31
0001551152
Common Stock, $0.01 Par Value
ABBV
0001551152
2024-09-06
2024-09-06
0001551152
us-gaap:CommonStockMember
exch:XNYS
2024-09-06
2024-09-06
0001551152
exch:XCHI
us-gaap:CommonStockMember
2024-09-06
2024-09-06
0001551152
abbv:SeniorNotes0.750Percentdue2027Member
exch:XNYS
2024-09-06
2024-09-06
0001551152
abbv:SeniorNotes2.125Percentdue2028Member
exch:XNYS
2024-09-06
2024-09-06
0001551152
abbv:SeniorNotes2.625Percentdue2028Member
exch:XNYS
2024-09-06
2024-09-06
0001551152
abbv:SeniorNotes2.125Percentdue2029Member
exch:XNYS
2024-09-06
2024-09-06
0001551152
abbv:SeniorNotes1.250Percentdue2031Member
exch:XNYS
2024-09-06
2024-09-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report (Date of earliest event
reported): September 6, 2024
ABBVIE
INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-35565 |
|
32-0375147 |
(State or other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
1
North Waukegan Road
North
Chicago, Illinois 60064-6400
(Address of principal executive offices)(Zip Code)
Registrant’s
telephone number, including area code: (847) 932-7900
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, $0.01 Par Value |
|
ABBV |
|
New
York Stock Exchange Chicago
Stock Exchange |
0.750%
Senior Notes due 2027 |
|
ABBV27 |
|
New
York Stock Exchange |
2.125%
Senior Notes due 2028 |
|
ABBV28 |
|
New
York Stock Exchange |
2.625%
Senior Notes due 2028 |
|
ABBV28B |
|
New
York Stock Exchange |
2.125%
Senior Notes due 2029 |
|
ABBV29 |
|
New
York Stock Exchange |
1.250%
Senior Notes due 2031 |
|
ABBV31 |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Common Stock, $0.01 Par Value |
ABBV |
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change
in Fiscal Year
On September 6, 2024, the Board of Directors of AbbVie Inc. (the “Company”)
approved an amendment and restatement of the Company’s By-laws (the “Third Amended and Restated By-laws”), effective
as of such date.
The amendments set forth in the Third Amended and Restated By-laws,
(1) update the address of Company’s registered agent, and (2) delete section 2.13(D)(iv) in its entirety. Company is the defendant in a stockholder class action complaint challenging the lawfulness of Section 2.13(D)(iv). Company believes
the provision is lawful but no longer has any practical value to the Company. Accordingly, Company does not believe defending this
provision is the best use of company resources.
The foregoing summary of the Third Amended and Restated By-laws does
not purport to be complete and is qualified in its entirety by reference to the full text of the Third Amended and Restated By-laws, which
is attached as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ABBVIE INC. |
|
|
|
|
Date: |
September 10, 2024 |
By: |
/s/ Perry C. Siatis |
|
|
|
Perry C. Siatis |
|
|
|
Executive Vice President, General |
|
|
|
Counsel and Secretary |
Exhibit 3.1
THIRD AMENDED AND RESTATED BY-LAWS
OF
ABBVIE INC.
Incorporated under the Laws of the State of Delaware
These Third Amended and Restated
By-laws (the “By-laws”) of AbbVie Inc., a Delaware corporation, are effective as of 11:59 p.m., Eastern time, on September 6,
2024 and hereby amend and restate the previous by-laws of AbbVie Inc., which are hereby deleted in their entirety and replaced with the
following:
Article I
OFFICES AND RECORDS
Section 1.1 Delaware
Office. The registered office of AbbVie Inc. (the “Corporation”) in the State of Delaware shall be located in
the City of Wilmington, County of New Castle, and the name and address of its registered agent is Corporate Creations Network Inc., 1521
Concord Pike, Suite 201, Wilmington, Delaware 19803, United States.
Section 1.2 Other
Offices. The Corporation may have such other offices, either inside or outside the State of Delaware, as the Board of Directors of
the Corporation (the “Board of Directors”) may designate or as the business of the Corporation may from time to time
require.
Section 1.3 Books
and Records. The books and records of the Corporation may be kept inside or outside the State of Delaware at such place or places
as may from time to time be designated by the Board of Directors.
Article II
STOCKHOLDERS
Section 2.1 Annual
Meeting. The annual meeting of the stockholders of the Corporation shall be held on such date and at such place and time as may be
fixed by resolution of the Board of Directors.
Section 2.2 Special
Meeting. Subject to the rights of the holders of any series of stock having a preference over the Common Stock of the Corporation
as to dividends, voting or upon liquidation (“Preferred Stock”) with respect to such series of Preferred Stock, special
meetings of the stockholders may be called only by the Chair of the Board of Directors, the Chief Executive Officer, any President, or
the Board of Directors pursuant to a resolution adopted by a majority of the total number of directors which the Corporation would have
if there were no vacancies (the “Whole Board”).
Section 2.3 Place
of Meeting. The Board of Directors or the Chair of the Board of Directors, as the case may be, may designate the place of meeting
for any annual or special meeting of the stockholders. If no designation is so made, the place of meeting shall be the principal office
of the Corporation. The Board of Directors or the Chair of the Board of Directors, as the case may be, may determine that a meeting of
stockholders shall, in addition to, or instead of, a physical meeting, be held by means of remote communication (including virtually)
as provided under the Delaware General Corporation Law (as it may be amended, the “DGCL”).
Section 2.4 Notice
of Meeting. Written or printed notice, stating the place, date and hour of the meeting, the means of remote communications, if any,
by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and, in the case of a special
meeting, the purpose or purposes for which the meeting is called, shall be delivered by the Corporation not less than ten (10) days
nor more than sixty (60) days before the date of the meeting, either personally, by electronic transmission in the manner provided in
Section 232 of the DGCL (except to the extent prohibited by Section 232(e) of the DGCL) or by mail, to each stockholder
of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in the United States
mail with postage thereon prepaid, addressed to the stockholder at such person’s address as it appears on the stock transfer books
of the Corporation. If notice is given by electronic transmission, such notice shall be deemed to be given at the times provided in the
DGCL. Such further notice shall be given as may be required by law. Meetings may be held without notice if all stockholders entitled
to vote are present, or if notice is waived by those not present in accordance with Section 8.4 of these By-laws. Any previously
scheduled meeting of the stockholders may be postponed, and, unless the Amended and Restated Certificate of Incorporation of the Corporation
(the “Certificate of Incorporation”) otherwise provides, any special meeting of the stockholders may be cancelled,
by resolution of the Board of Directors upon public notice given prior to the date previously scheduled for such meeting of stockholders.
Section 2.5 Quorum
and Adjournment. Except as otherwise provided by law or by the Certificate of Incorporation, the holders of a majority of the outstanding
shares of the Corporation entitled to vote generally in the election of directors (the “Voting Stock”), represented
in person or by proxy, shall constitute a quorum at a meeting of stockholders, except that when specified business is to be voted on
by a class or series of stock voting as a class, the holders of a majority of the shares of such class or series shall constitute a quorum
of such class or series for the transaction of such business. The Chair of the Board of Directors or the President may adjourn the meeting
from time to time, whether or not there is a quorum. No notice of the time and place of adjourned meetings need be given except as required
by law. The stockholders present at a duly called meeting at which a quorum is present may continue to transact business until adjournment,
notwithstanding the withdrawal of enough stockholders to leave less than a quorum.
Section 2.6 Proxies.
At all meetings of stockholders, a stockholder may vote by proxy executed in writing (or in such manner prescribed by the DGCL) by the
stockholder, or by such person’s duly authorized attorney in fact.
Section 2.7 Order
of Business.
(A) Annual
Meetings of Stockholders. At any annual meeting of the stockholders, only such nominations of persons for election to the Board of
Directors shall be made, and only such other business shall be conducted or considered, as shall have been properly brought before the
meeting. For nominations to be properly made at an annual meeting, and proposals of other business to be properly brought before an annual
meeting, nominations and proposals of other business must be: (a) specified in the Corporation’s notice of meeting (or any
supplement thereto) given by or at the direction of the Board of Directors, (b) otherwise properly made at the annual meeting, by
or at the direction of the Board of Directors or (c) otherwise properly requested to be brought before the annual meeting by a stockholder
of the Corporation in accordance with these By-laws. For nominations of persons for election to the Board of Directors or proposals of
other business to be properly requested by a stockholder to be made at an annual meeting, a stockholder must (i) be a stockholder
of record at the time of giving of notice of such annual meeting by or at the direction of the Board of Directors and at the time of
the annual meeting, (ii) be entitled to vote at such annual meeting and (iii) comply with the procedures set forth in these
By-laws as to such business or nomination. The immediately preceding sentence shall be the exclusive means for a stockholder to make
nominations or other business proposals (other than matters properly brought under Rule 14a-8 under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”) and included in the Corporation’s notice of meeting) before an annual
meeting of stockholders.
(B) Special
Meetings of Stockholders. At any special meeting of the stockholders, only such business shall be conducted or considered, as shall
have been properly brought before the meeting pursuant to the Corporation’s notice of meeting. To be properly brought before a
special meeting, proposals of business must be (a) specified in the Corporation’s notice of meeting (or any supplement thereto)
given by or at the direction of the Board of Directors, or (b) otherwise properly brought before the special meeting, by or at the
direction of the Board of Directors.
Nominations of persons for election
to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Corporation’s
notice of meeting (a) by or at the direction of the Board of Directors or (b) provided that the Board of Directors has determined
that directors shall be elected at such meeting, by any stockholder of the Corporation who (i) is a stockholder of record at the
time of giving of notice of such special meeting and at the time of the special meeting, (ii) is entitled to vote at the meeting,
and (iii) complies with the procedures set forth in these By-laws as to such nomination. The immediately preceding sentence
shall be the exclusive means for a stockholder to make nominations (other than matters properly brought under Rule 14a-8 under the
Exchange Act and included in the Corporation’s notice of meeting) before a special meeting of stockholders.
(C) General.
The Board of Directors may adopt by resolution such rules, regulations and procedures for the conduct of any meeting of stockholders
of the Corporation as it shall deem appropriate, including such guidelines and procedures as it may deem appropriate regarding the participation
by means of remote communication of stockholders and proxyholders not physically present at a meeting. Except to the extent inconsistent
with such rules, regulations and procedures as adopted by the Board of Directors, the Chair of any meeting of stockholders shall have
the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such Chair,
are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors
or prescribed by the Chair of the meeting, may include the following: (a) the establishment of an agenda or order of business for
the meeting, (b) rules and procedures for maintaining order at the meeting and the safety of those present, including regulation
of the manner of voting and the conduct of discussion, (c) limitations on attendance at or participation in the meeting to stockholders
of record of the Corporation, their duly authorized and constituted proxies or such other persons as the Chair of the meeting shall determine,
(d) restrictions on entry to the meeting after the time fixed for the commencement thereof, (e) limitations on the time allotted
to questions or comments by participants and (f) restrictions on the use of cell phones, audio or video recording devices and similar
devices at the meeting. Except as otherwise provided by law, the Certificate of Incorporation or these By-laws, in addition to making
any other determinations that may be appropriate to the conduct of the meeting, the Chair of any annual or special meeting of stockholders
shall have the power to determine whether a nomination or any other business proposed to be brought before the meeting was made or proposed,
as the case may be, in accordance with these By-laws and, if any proposed nomination or other business is not in compliance with these
By-laws, to declare that no action shall be taken on such nomination or other proposal and such nomination or other proposal shall be
disregarded. Unless and to the extent determined by the Board of Directors or the Chair of the meeting, meetings of stockholders shall
not be required to be held in accordance with the rules of parliamentary procedure. The Chair of the meeting shall announce at the
meeting when the polls for each matter to be voted upon at the meeting will be opened and closed. After the polls close, no ballots,
proxies or votes or any revocations or changes thereto shall be accepted. The Chair of the meeting shall have the power, right and authority
to convene, recess or adjourn any meeting of stockholders.
Notwithstanding anything to the
contrary in these By-laws, if the Noticing Stockholder or a qualified representative (both as defined below) of such stockholder does
not appear at the annual meeting or a special meeting, as applicable, to present a nomination or business proposal, such nomination shall
be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been
received by the Corporation.
Section 2.8 Advance
Notice of Stockholder Business and Nominations.
(A) Annual
Meeting of Stockholders. Without qualification or limitation in addition to any other applicable requirements, for any nominations
or any other business to be properly brought before an annual meeting by a stockholder of record pursuant to Section 2.7(A) of
these By-laws, the stockholder of record bringing the notice (“Noticing Stockholder”) must have delivered timely notice thereof
in proper form (including, in the case of nominations, the completed and signed questionnaire, representation and agreement required
by Section 2.9 of these By-laws), and timely updates and supplements thereof, in writing to the Secretary, and such other
business must otherwise be a proper matter for stockholder action.
To be timely, the Noticing Stockholder’s
notice shall be delivered to the Secretary at the principal executive offices of the Corporation not earlier than the Close of Business
on the 120th day and not later than the Close of Business on the 90th day prior to the first anniversary of the preceding year’s
annual meeting; provided, however, that in the event that the date of the annual meeting is more than 30 days before or
more than 60 days after such anniversary date, notice by the Noticing Stockholder must be so delivered not earlier than the Close of
Business on the 120th day prior to the date of such annual meeting and not later than the Close of Business on the later of the 90th
day prior to the date of such annual meeting or, if the first public announcement of the date of such annual meeting is less than 100
days prior to the date of such annual meeting, the 10th day following the day on which public announcement of the date of such meeting
is first made by the Corporation. In no event shall any adjournment, recess or postponement of an annual meeting, or the public announcement
thereof, commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above.
Notwithstanding anything in the
immediately preceding paragraph to the contrary, in the event that the number of directors to be elected to the Board of Directors is
increased by the Board of Directors, and there is no public announcement by the Corporation naming all of the director nominees or specifying
the size of the increased Board of Directors at least 10 days prior to the deadline for nominations that would otherwise be applicable
under this Section 2.8(A), a Noticing Stockholder’s notice required by this Section 2.8(A) shall also be
considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the
Secretary at the principal executive offices of the Corporation not later than the Close of Business on the 10th day following the day
on which such public announcement is first made by the Corporation.
In addition, to be considered
timely, a Noticing Stockholder’s notice shall further be updated and supplemented, if necessary, so that the information provided
or required to be provided in such notice shall be true and correct as of the record date for the meeting and as of the date that is
ten (10) Business Days prior to the meeting or any adjournment, recess or postponement thereof, and such update and supplement shall
be delivered to the Secretary at the principal executive offices of the Corporation not later than five (5) Business Days after
the record date for the meeting in the case of the update and supplement required to be made as of the record date, and not later than
eight (8) Business Days prior to the date for the meeting or any adjournment, recess or postponement thereof in the case of the
update and supplement required to be made as of ten (10) Business Days prior to the meeting or any adjournment, recess or postponement
thereof. If the Noticing Stockholder has delivered to the Corporation a notice relating to the nomination of directors, the Noticing
Stockholder shall deliver to the Corporation no later than eight (8) Business Days prior to the date of the meeting reasonable evidence
that it has complied with the requirements of Rule 14a-19 of the Exchange Act. For the avoidance of doubt, the obligation to update
and supplement as set forth in this paragraph or any other Section of these By-laws shall not limit the Corporation’s rights
with respect to any deficiencies in any notice provided by a Noticing Stockholder, extend any applicable deadlines hereunder, or under
any other provision of the By-laws, or enable or be deemed to permit a Noticing Stockholder who has previously submitted notice hereunder,
or under any other provision of the By-laws, to amend or update any proposal or to submit any new proposal, whether by changing or adding
nominees, matters, business and or resolutions proposed to be brought before a meeting of the stockholders or otherwise.
(B) Special
Meetings of Stockholders. In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or
more directors to the Board of Directors, the Noticing Stockholder may nominate a person or persons (as the case may be) for election
to such position(s) as specified in the Corporation’s notice of meeting, provided that the Noticing Stockholder delivers
timely notice thereof in proper form (including the completed and signed questionnaire, representation and agreement required by Section 2.9
of these By-laws), and timely updates and supplements thereof, in writing, to the Secretary, in addition to any other applicable
requirements.
To be timely, a Noticing Stockholder’s
notice shall be delivered to the Secretary at the principal executive offices of the Corporation not earlier than the Close of Business
on the 120th day prior to the date of such special meeting and not later than the Close of Business on the later of the 90th day prior
to the date of such special meeting or, if the first public announcement of the date of such special meeting is less than 100 days prior
to the date of such special meeting, the 10th day following the day on which public announcement is first made of the date of the special
meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. In no event shall any adjournment, recess
or postponement of a special meeting of stockholders, or the public announcement thereof, commence a new time period (or extend any time
period) for the giving of a stockholder’s notice as described above.
In addition, to be considered
timely, a Noticing Stockholder’s notice shall further be updated and supplemented, if necessary, so that the information provided
or required to be provided in such notice shall be true and correct as of the record date for the meeting and as of the date that is
ten (10) Business Days prior to the meeting or any adjournment, recess or postponement thereof, and such update and supplement shall
be delivered to the Secretary at the principal executive offices of the Corporation not later than five (5) Business Days after
the record date for the meeting in the case of the update and supplement required to be made as of the record date, and not later than
eight (8) Business Days prior to the date for the meeting, any adjournment, recess or postponement thereof in the case of the update
and supplement required to be made as of ten (10) Business Days prior to the meeting or any adjournment, recess or postponement
thereof.
(C) Disclosure
Requirements.
(i) To
be in proper form, a Noticing Stockholder’s notice (whether given pursuant to Section 2.7(A) or 2.7(B) of
these By-laws) to the Secretary must include the following, as applicable.
(1) As
to the Noticing Stockholder and the beneficial owner, if any, on whose behalf the nomination or proposal is made (collectively with the
Noticing Stockholder, the “Holders” and each a “Holder”), a Noticing Stockholder’s notice must set forth:
(i) the name and address of each Holder, as they appear on the Corporation’s books and the name and address of each Stockholder
Associated Person, if any, (ii) (A) the class or series and number of shares of stock or any other security of the Corporation
which are, directly or indirectly, owned beneficially or of record by each Holder and each Stockholder Associated Person, if any (provided
that, for the purposes of this Section 2.8(C), any such person shall in all events be deemed to beneficially own any shares
of the Corporation as to which such person has a right to acquire beneficial ownership at any time in the future (whether such right
is exercisable immediately or only after the passage of time or the fulfillment of a condition or both)), and the number of shares that
have been held by each Holder or Stockholder Associated Person, if any, for more than one year, (B) a description of any profits
interest, option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege
or a settlement payment or mechanism at a price related to any class or series of shares of stock or any other security of the Corporation
or with a value derived in whole or in part from the value of any class or series of shares of the Corporation, or any derivative or
synthetic arrangement having the characteristics of a long position in any class or series of shares of stock or any other security of
the Corporation, or any contract, derivative, swap or other transaction or series of transactions designed to produce economic benefits
and risks that correspond substantially to the ownership of any class or series of shares of stock or any other security of the Corporation,
including due to the fact that the value of such contract, derivative, swap or other transaction or series of transactions is determined
by reference to the price, value or volatility of any class or series of shares of stock or any other security of the Corporation, whether
or not such instrument, contract or right shall be subject to settlement in the underlying class or series of shares of the Corporation,
through the delivery of cash or other property, or otherwise, and without regard to whether the Holder and the Stockholder Associated
Person, if any, or any Affiliates or Associates or others acting in concert therewith, may have entered into transactions that hedge
or mitigate the economic effect of such instrument, contract or right, or any other direct or indirect opportunity to profit or share
in any profit derived from any increase or decrease in the value of shares of stock or any other security of the Corporation (any of
the foregoing, a “Derivative Instrument”) directly or indirectly owned or held, including beneficially, by each Holder
or Stockholder Associated Person, (C) a description of any proxy, contract, arrangement, understanding, or relationship pursuant
to which each Holder or Stockholder Associated Person, if any, has a right to vote or has granted a right to vote to any class or series
of shares of stock or any other security of the Corporation, (D) a description of any agreement, arrangement, understanding, relationship
or otherwise, including any repurchase or similar so-called “stock borrowing” agreement or arrangement, involving each Holder
or Stockholder Associated Person, if any, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce the economic
risk (of ownership or otherwise) of any class or series of the shares of stock or any other security of the Corporation by, manage the
risk of share price changes for, or increase or decrease the voting power of, such Holder or Stockholder Associated Person with respect
to any class or series of the shares of stock or any other security of the Corporation, or which provides, directly or indirectly, the
opportunity to profit or share in any profit derived from any decrease in the price or value of any class or series of the shares of
stock or any other security the Corporation (any of the foregoing, a “Short Interest”), and any Short Interest held
by each Holder or Stockholder Associated Person, if any, within the last 12 months (E) any rights to dividends or payments in lieu
of dividends on the shares of stock or any other security of the Corporation owned beneficially by each Holder or each Stockholder Associated
Person, if any, that are separated or separable from the underlying shares of stock or other security of the Corporation, (F) any
proportionate interest in shares of stock or other securities of the Corporation or Derivative Instruments held, directly or indirectly,
by each Holder or each Stockholder Associated Person, if any, or held directly or indirectly by a general or limited partnership or other
entity in which any Holder or Stockholder Associated Person, if any, is directly or indirectly a partner or manager or has another form
of equity ownership, (G) a description of any performance-related fees (other than an asset-based fee) that each Holder or each
Stockholder Associated Person, if any, or an Affiliate of such Holder or Stockholder Associated Person, is or may be entitled to based
on any increase or decrease in the value of shares of stock or other securities of the Corporation or Derivative Instruments, if any,
(H) any direct or indirect legal, economic or financial interest (including short interest) of each Holder and each Stockholder
Associated Person, if any, in the outcome of any (x) vote to be taken at any annual or special meeting of stockholders of the Corporation
or (y) any meeting of stockholders of any other entity with respect to any matter that is related, directly or indirectly, to any
nomination or business proposed by any Holder under these By-Laws, (I) any direct or indirect legal, economic or financial interest
or any Derivative Instruments or Short Interests in any principal competitor of the Corporation held by each Holder and each Stockholder
Associated Person, if any, (J) a description of any direct or indirect interest of such stockholder in any contract with the Corporation,
any Affiliate of the Corporation or any principal competitor of the Corporation (including, in any such case, any employment agreement,
collective bargaining agreement or consulting agreement), and (K) any material pending or threatened action, suit
or proceeding (whether civil, criminal, investigative, administrative or otherwise) in which any Holder or Stockholder Associated Person,
if any, is, or is reasonably expected to be made, a party or material participant involving the Corporation or any of its officers, directors
or employees, or any Affiliate of the Corporation, or any officer, director or employee of such Affiliate (sub-clauses (A) through
(K) of this Section 2.8(C)(i)(1)(ii) shall be referred to as the “Specified Information”), (iii) any
other information relating to each Holder and each Stockholder Associated Person, if any, that would be required to be disclosed in a
proxy statement and form of proxy or other filings required to be made in connection with solicitations of proxies for, as applicable,
the proposal and/or for the election of directors in a contested election pursuant to Section 14 of the Exchange Act and the rules and
regulations promulgated thereunder, (vi) a certification that each Holder and each Stockholder Associated Person, if any, has complied
with all applicable federal, state and other legal requirements in connection with its acquisition of shares or other securities of the
Corporation and such person’s acts or omissions as a stockholder of the Corporation, (vii) the names and addresses of other
stockholders (including beneficial owners) known by any Holder or Stockholder Associated Person, if any, to support such proposal or
nomination or nominations, and to the extent known, the class and number of all shares of the Corporation’s capital stock
owned beneficially or of record by such other stockholder(s) or other beneficial owner(s), and (viii) a representation
by the Noticing Stockholder as to the accuracy of the information set forth in the notice;
(2) If
the Noticing Stockholder’s notice relates to any business other than a nomination of a director or directors that the Noticing
Stockholder proposes to bring before the meeting, such notice must, in addition to the matters set forth in Section 2.8(C)(i)(1) above,
also set forth: (i) a brief description of the business desired to be brought before the meeting, the reasons for conducting such
business at the meeting and any material interest of each Holder and each Stockholder Associated Person, if any, in such business, (ii) the
text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such proposal
or business includes a proposal to amend the By-laws of the Corporation, the text of the proposed amendment), and (iii) a
description of all agreements, arrangements and understandings between each Holder and each Stockholder Associated Person, if any, and
any other person or persons (including their names) in connection with the proposal of such business by the Noticing Stockholder;
(3) As
to each person, if any, whom the Noticing Stockholder proposes to nominate for election or reelection to the Board of Directors, the
Noticing Stockholder’s notice must, in addition to the matters set forth in Section 2.8(C)(i)(1) the name, age
and address (business and residential) of the proposed nominee, (ii) a complete biography and statement of the proposed nominee’s
qualifications, including the principal occupation or employment of such person (at present and for the past five years), (iii) the
Specified Information for such person and any member of the immediate family of such person, or any Affiliate or Associate (as such terms
are defined below) of such person, or any person acting in concert therewith, (iv) a complete and accurate description of all direct
and indirect compensation and other monetary or non-monetary agreements, arrangements and understandings (whether written or oral) existing
presently or that existed during the past three years, and any other material relationships, between or among the Holders or any Stockholder
Associated Person (as such terms are defined below), on the one hand, and such person and any member of the immediate family of such
person, and such person’s respective Affiliates and Associates, or others acting in concert therewith, or any other person or persons,
on the other hand (including the names of such persons and all biographical and related party transaction and other information that
would be required to be disclosed pursuant to the federal and state securities laws, including Rule 404 promulgated under Regulation
S-K under the Securities Act of 1933 (the “Securities Act”) (or any successor provision), if any Holder or any Stockholder
Associated Person were the “registrant” for purposes of such rule and such person were a director or executive officer
of such registrant), (v) information relevant to a determination of whether the proposed nominee can be considered an independent
director and (vi) any other information relating to such person that would be required to be disclosed in a proxy statement or any
other filings required to be made in connection with solicitations of proxies for the election of directors in a contested election or
that is otherwise required pursuant to and in accordance with Section 14 of the Exchange Act and the rules and regulations
promulgated thereunder and any applicable stock exchange rule (including such person’s written consent to being named in the
proxy statement as a nominee in any proxy statement for a meeting for the election of directors and any associated form of proxy and
to serving as a director if elected);
(4) With
respect to each person, if any, whom the Noticing Stockholder proposes to nominate for election or reelection to the Board of Directors,
the Noticing Stockholder’s notice must, in addition to the matters set forth in paragraphs (A) and (C) above, also
include a completed and signed questionnaire, representation and agreement required by Section 2.9 of these By-laws.
(5) The
Corporation may, as a condition to any such nomination or business being deemed properly brought before an annual or special meeting,
require any proposed nominee or the Noticing Stockholder to deliver to the Secretary, within five (5) Business Days of any such
request, such other information as may be reasonably requested by the Corporation, including such other information (a) as may be
reasonably required by the Board of Directors, in its sole discretion to determine (i) the eligibility of such proposed nominee
to serve as a director of the Corporation and (ii) whether such proposed nominee qualifies as an “independent director”
or “audit committee financial expert” under applicable law, securities exchange rule or regulation, or any publicly
disclosed corporate governance guideline or committee charter of the Corporation and (b) that the Board of Directors determines,
in its sole discretion, could be material to a reasonable stockholder’s understanding of the independence, or lack thereof, of
such proposed nominee.
(ii) For
purposes of these By-laws,
(A) “Affiliate”
shall have the meaning attributed to such term in Rule 12b-2 under the Exchange Act.
(B) “Associate”
shall have the meaning attributed to such term in Rule 12b-2 under the Exchange Act.
(C) “Business
Day” shall mean each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in Chicago, Illinois
or New York, New York are authorized or obligated by law or executive order to close.
(D) “Close
of Business” on a particular day shall mean 5:00 p.m. local time at the principal executive offices of the Corporation,
and if an applicable deadline falls on the Close of Business on a day that is not a Business Day, then the applicable deadline shall
be deemed to be the Close of Business on the immediately preceding Business Day.
(E) “delivery”
of any notice or materials by a stockholder as required to be “delivered” shall mean, both (i) hand delivery, overnight
courier service, or by certified or registered mail, return receipt requested, in each case to the Secretary at the principal executive
offices of the Corporation, and (ii) electronic mail to the Secretary.
(F) “public
announcement” shall mean disclosure in a press release reported by a national news service or in a document publicly filed
by the Corporation with the Securities and Exchange Commission (“SEC”) pursuant to Section 13, 14 or 15(d) of
the Exchange Act and the rules and regulations promulgated thereunder.
(G) “qualified
representative” of a stockholder of the Corporation shall mean, a person must be a duly authorized officer, manager or partner
of such stockholder or authorized by a writing executed by such stockholder (or a reliable reproduction or electronic transmission of
the writing) delivered to the Secretary at the principal executive offices of the Corporation no later than eight (8) Business Days
prior to the date of the applicable stockholder meeting stating that such person is authorized to act for such stockholder as proxy at
such meeting of stockholders, and such person must produce proof that he or she is a duly authorized officer, manager or partner of such
stockholder or of such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, as well
as valid government-issued photo identification, at the meeting of stockholders of the Corporation.
(H) “Stockholder
Associated Person” shall mean, as to any Holder, (i) any person acting in concert with such Holder, (ii) any person
controlling, controlled by or under common control with such Holder or any of their respective Affiliates and Associates, or person acting
in concert therewith, and (iii) any member of the immediate family of such Holder or an Affiliate or Associate
of such Holder.
For purposes of these By-Laws,
the words “include,” “includes” or “including” shall be deemed to be followed by the words “without
limitation.” Where a reference in these By-Laws is made to any statue or regulation, such reference shall be to (1) the statute
or regulation as amended from time to time (except as context may otherwise require) and (2) any rules or regulations promulgated
thereunder.
(iii) Notwithstanding
the provisions of these By-laws, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and
regulations thereunder with respect to the matters set forth in these By-laws; provided, however, that any references in these By-laws
to the Exchange Act or the rules promulgated thereunder are not intended to and shall not limit the separate and additional requirements
set forth in these By-laws with respect to nominations or proposals as to any other business to be considered pursuant to Section 2.7
of these By-laws.
(iv) Nothing
in these By-laws shall be deemed to affect any rights (i) of stockholders to request inclusion of proposals in the Corporation’s
proxy statement pursuant to Rule 14a-8 under the Exchange Act or (ii) of the holders of any series of Preferred Stock if and
to the extent provided for under law, the Certificate of Incorporation or these By-laws. Subject to Rule 14a-8 under the Exchange
Act, nothing in these By-laws shall be construed to permit any stockholder, or give any stockholder the right, to include or have disseminated
or described in the Corporation’s proxy statement any nomination of director or directors or any other business proposal except
as explicitly provided in Section 2.13 of these By-laws.
Section 2.9 Submission
of Questionnaire, Representation and Agreement. To be eligible to be a nominee for election or reelection as a director of the Corporation,
a person nominated by a Noticing Stockholder for election or reelection to the Board of Directors, in addition to the other requirements
of this Article II, must deliver (in accordance with the time periods prescribed for delivery of notice under Section 2.8
and Section 2.13, as applicable of these By-laws) to the Secretary at the principal executive offices of the Corporation
a written questionnaire with respect to the background and qualification of such person and the background of any other person or entity
on whose behalf the nomination is being made (which questionnaire shall be provided by the Secretary upon written request of any stockholder
of record identified by name within five (5) Business Days of such request), and a written representation and agreement (in the
form provided by the Secretary upon written request of any stockholder of record identified by name within five (5) Business Days
of such written request) that such person (A) is not and will not become a party to (1) any agreement, arrangement or understanding
(whether written or oral) with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected
as a director of the Corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not been
disclosed to the Corporation or (2) any Voting Commitment that could limit or interfere with such person’s ability to comply,
if elected as a director of the Corporation, with such person’s fiduciary duties under applicable law, (B) is not and will
not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to
any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not
been disclosed therein, (C) will comply with the Corporation’s stock ownership guidelines for directors, if any, and has disclosed
therein whether all or any portion of securities of the Corporation were purchased with any financial assistance provided by any other
person and whether any other person has any interest in such securities, (D) in such person’s individual capacity and on behalf
of any person or entity on whose behalf the nomination is being made, would be in compliance, if elected as a director of the Corporation,
and will comply, with all applicable rules of the exchanges upon which the securities of the Corporation are listed and all applicable
corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation
publicly disclosed from time to time, (E) will abide by the requirements of Section 2.10 of these By-laws and (F) in
such person’s individual capacity and on behalf of any Holder on whose behalf the nomination is being made, intends to serve a
full term if elected as a director of the Corporation.
Section 2.10 Procedure
for Election of Directors; Required Vote.
(A) Except
as set forth below, election of directors at all meetings of the stockholders at which directors are to be elected shall be by ballot,
and, subject to the rights of the holders of any series of Preferred Stock to elect directors under specified circumstances, a majority
of the votes cast at any meeting for the election of directors at which a quorum is present shall elect directors. For purposes of this
By-law, a majority of votes cast shall mean that the number of shares voted “for” a director’s election exceeds 50%
of the number of votes cast with respect to that director’s election. Votes cast shall include direction to withhold authority
or to vote against in each case and exclude abstentions with respect to that director’s election. Notwithstanding the foregoing,
in the event of a “contested election” of directors, directors shall be elected by the vote of a plurality of the votes cast
at any meeting for the election of directors at which a quorum is present. For purposes of this By-law, a “contested election”
shall mean any election of directors in which the number of candidates for election as directors exceeds the number of directors to be
elected, with the determination thereof being made by the Secretary as of the close of the applicable notice of nomination period set
forth in Section 2.8 of these By-laws or under applicable law, based on whether one or more notice(s) of nomination
were timely filed in accordance with Section 2.8 or Section 2.13, as applicable; provided, however,
that the determination that an election is a “contested election” shall be determinative only as to the timeliness of a notice
of nomination and not otherwise as to its validity. If, prior to the time the Corporation mails its initial proxy statement in connection
with such election of directors, one or more notices of nomination are withdrawn such that the number of candidates for election as director
no longer exceeds the number of directors to be elected, the election shall not be considered a contested election, but in all other
cases, once an election is determined to be a contested election, directors shall be elected by the vote of a plurality of the votes
cast.
(B) If
a nominee for director who is an incumbent director is not elected and no successor has been elected at such meeting, the director shall
promptly tender such person’s resignation to the Board of Directors in accordance with the agreement contemplated by Section 2.9
of these By-laws. The Nominations and Governance Committee shall make a recommendation to the Board of Directors as to whether to
accept or reject the tendered resignation, or whether other action should be taken. The Board of Directors shall act on the tendered
resignation, taking into account the Nominations and Governance Committee’s recommendation, and publicly disclose (by a press release,
a filing with the SEC or other broadly disseminated means of communication) its decision regarding the tendered resignation and the rationale
behind the decision within 90 days from the date of the certification of the election results. The Nominations and Governance Committee
in making its recommendation, and the Board of Directors in making its decision, may each consider any factors or other information that
it considers appropriate and relevant. The director who tenders a resignation shall not participate in the recommendation of the Nominations
and Governance Committee or the decision of the Board of Directors with respect to such person’s resignation. If such incumbent
director’s resignation is not accepted by the Board of Directors, such director shall continue to serve until the next annual meeting
and until such person’s successor is duly elected, or such person’s earlier resignation or removal. If a director’s
resignation is accepted by the Board of Directors pursuant to this By-law, or if a nominee for director is not elected and the nominee
is not an incumbent director, then the Board of Directors, in its sole discretion, may fill any resulting vacancy pursuant to the provisions
of Section 3.10 of these By-laws or may decrease the size of the Board of Directors pursuant to the provisions of Section 3.2
of these By-laws.
(C) Except
as otherwise provided by law, the Certificate of Incorporation, or these By-laws, in all matters other than the election of directors,
the affirmative vote of a majority of the shares present in person or represented by proxy at the meeting and entitled to vote on the
matter shall be the act of the stockholders.
Section 2.11 Inspectors
of Elections; Opening and Closing the Polls.
(A) The
Board of Directors by resolution shall appoint one or more inspectors, which inspector or inspectors may, but does not need to, include
individuals who serve the Corporation in other capacities, including, without limitation, as officers, employees, agents or representatives,
to act at the meetings of stockholders and make a written report thereof. One or more persons may be designated as alternate inspectors
to replace any inspector who fails to act. If no inspector or alternate has been appointed to act or is able to act at a meeting of stockholders,
the Chair of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before discharging such person’s
duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best
of such person’s ability. The inspectors shall have the duties prescribed by law.
(B) The
Chair of the meeting shall be appointed by the inspector or inspectors to fix and announce at the meeting the date and time of the opening
and the closing of the polls for each matter upon which the stockholders will vote at a meeting.
Section 2.12 No
Stockholder Action by Written Consent. Subject to the rights of the holders of any series of Preferred Stock with respect to such
series of Preferred Stock, any action required or permitted to be taken by the stockholders of the Corporation must be effected at an
annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders.
Section 2.13 Stockholder
Nominations Included in the Corporation’s Proxy Materials.
(A) Inclusion
of Nominee in Proxy Statement. Subject to the provisions of this Section 2.13, if expressly requested in the relevant
Nomination Notice (as defined below), the Corporation shall include in its proxy statement for annual meetings of stockholders at which
directors will be elected beginning with the Corporation’s 2017 annual meeting of stockholders:
(i) the
name of any qualifying person nominated for election (the “Nominee”), which shall also be included on the Corporation’s
form of proxy and ballot, by any Eligible Holder (as defined below) or group of up to 20 Eligible Holders that has (individually and
collectively, in the case of a group) satisfied, as determined by the Board of Directors or its designee, acting in good faith, all applicable
conditions and complied with all applicable procedures set forth in this Section 2.13 (such Eligible Holder or group of Eligible
Holders being a “Nominating Stockholder”);
(ii) disclosure
about the Nominee and the Nominating Stockholder that the Corporation determines is required under the rules of the SEC or other
applicable law to be included in the proxy statement;
(iii) a
single statement included by the Nominating Stockholder in the Nomination Notice for inclusion in the proxy statement in support of each
Nominee(s)’ election to the Board of Directors (subject, without limitation, to Section 2.13(F)), if such statement
does not exceed 500 words; and
(iii) any
other information that the Corporation or the Board of Directors determines, in their discretion, to include in the proxy statement or
other materials relating to the nomination of the Nominee, including, without limitation, any statement or other soliciting material
in opposition to or with respect to the nomination and any of the information provided pursuant to this Section or otherwise.
(B) Maximum
Number of Nominees.
The Corporation
shall not be required to include in the proxy statement for an annual meeting of stockholders more Nominees than that number of directors
constituting 25% of the total number of directors of the Corporation in office on the last day on which a Nomination Notice may be submitted
pursuant to this Section 2.13 (rounded down to the nearest whole number) (the “Maximum Number”). The Maximum
Number for a particular annual meeting shall be reduced by:
(i) such
Nominee(s) nominated by a Nominating Stockholder pursuant to this Section 2.13 for such annual meeting who are subsequently
withdrawn or whom the Board of Directors itself decides to nominate for election at such annual meeting or otherwise appoint to the Board
of Directors (provided that a Nominee appointed pursuant to an agreement, arrangement or other understanding with a stockholder or group
of stockholders shall be counted only once under clauses (i) and (iii) of this Section 2.13(B));
(ii) incumbent
director(s) who had been Nominees nominated by a Nominating Stockholder pursuant to this Section 2.13 with respect to
either of the two preceding annual meetings other than any such director referred to in this clause (ii) whose term
of office will expire at such annual meeting and who is not seeking (or agreeing) to be nominated at such annual meeting for another
term of office; and
(iii) director(s) in
office or director candidate(s) that in either case were elected or appointed to the Board of Directors or will be included in the
Corporation’s proxy statement with respect to such annual meeting as an unopposed (by the Corporation) nominee, pursuant to an
agreement, arrangement or other understanding with a stockholder or group of stockholders (other than any such agreement, arrangement
or understanding entered into in connection with an acquisition of shares of the stock of the Corporation entitled to vote generally
in the election of directors, by such stockholder or group of stockholders, from the Corporation), other than any such director referred
to in this clause (iii) who at the time of such annual meeting will have served as a director continuously for at least
three years;
provided, that in no circumstance
shall the Maximum Number exceed the number of directors to be elected at the applicable annual meeting as noticed by the Corporation;
and, provided, further, in the event that one or more vacancies for any reason occurs on the Board of Directors before
the date of the annual meeting, and the Board of Directors resolves to reduce the size of the board in connection therewith, the Maximum
Number shall be calculated based on the number of directors in office as so reduced.
Any Nominating Stockholder submitting
more than one Nominee for inclusion in the Corporation’s proxy statement pursuant to this Section 2.13 shall rank such
Nominees based on the order that the Nominating Stockholder prefers such Nominees to be selected for inclusion in the Corporation’s
proxy statement and include such specified rank in its Nomination Notice. If the number of Nominees pursuant to this Section 2.13
for any annual meeting of stockholders exceeds the Maximum Number then, the highest ranking Nominee who meets the requirements of
this Section 2.13 from each Nominating Stockholder will be selected for inclusion in the proxy statement until the Maximum
Number is reached, going in order of the amount (largest to smallest) of the ownership position as disclosed in each Nominating Stockholder’s
Nomination Notice. If the Maximum Number is not reached after the highest ranking Nominee from each Nominating Stockholder has been selected,
this selection process will continue as many times as necessary, following the same order each time, until the Maximum Number is reached.
If, after the deadline for submitting a Nomination Notice as set forth in Section 2.13(D), a Nominating Stockholder becomes
ineligible or withdraws its nomination or a Nominee becomes unwilling to serve on the Board of Directors, whether before or after the
mailing of the definitive proxy statement, then the nomination shall be disregarded, and the Corporation: (1) shall not be required
to include in its proxy statement or on any ballot or form of proxy the disregarded Nominee or any successor or replacement nominee proposed
by the Nominating Stockholder or by any other Nominating Stockholder and (2) may otherwise communicate to its stockholders, including
without limitation by amending or supplementing its proxy statement or ballot or form of proxy, that the Nominee will not be included
as a Nominee in the proxy statement or on any ballot or form of proxy and will not be voted on at the annual meeting.
(C) Eligibility
of Nominating Stockholder.
An “Eligible
Holder” is a person who has either (1) been a record holder of the shares of common stock used to satisfy the eligibility
requirements in this Section 2.13(C) continuously for the three-year period specified in Subsection (ii) below
or (2) provides to the Secretary of the Corporation, within the time period referred to in Section 2.13(D), evidence
of continuous ownership of such shares for such three-year period from one or more securities intermediaries in a form that the Board
of Directors or its designee, acting in good faith, determines would be deemed acceptable for purposes of a shareholder proposal under
Rule 14a-8(b)(2) under the Exchange Act (or any successor rule).
An Eligible Holder or group of
up to 20 Eligible Holders may submit a nomination in accordance with this Section 2.13 only if the person or group (in the
aggregate) has continuously owned at least the Minimum Number (as defined below) of shares of the Corporation’s common stock throughout
the three-year period preceding and including the date of submission of the Nomination Notice, and continues to own at least the Minimum
Number through the date of the annual meeting. A group of funds shall be treated as one Eligible Holder for the purpose of determining
the aggregate number of stockholders in this paragraph (C) if such Eligible Holder shall provide, together with the Nomination
Notice, documentation reasonably satisfactory to the Corporation that demonstrates that the funds are (A) under common management
and investment control, (B) under common management and funded primarily by the same employer, or (C) a “group of investment
companies” as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended, and
each fund otherwise meets the requirements set forth in this Section 2.13. A record holder acting on behalf of one or more
beneficial owners will not be counted separately as a stockholder with respect to the shares owned by beneficial owners on whose behalf
such record holder has been directed in writing to act, but each such beneficial owner will be counted separately, subject to the other
provisions of this paragraph (C), for purposes of determining the number of stockholders whose holdings may be considered as part
of an Eligible Holder’s holdings. For the avoidance of doubt, in the event of a nomination by a group of Eligible Holders, any
and all requirements and obligations for an individual Eligible Holder that are set forth in this Section 2.13, including
the minimum holding period, shall apply to each member of such group; provided, however, that the Minimum Number shall apply to the ownership
of the group in the aggregate. Should any stockholder withdraw from a group of Eligible Holders at any time prior to the annual meeting
of stockholders, the group of Eligible Holders shall only be deemed to own the shares held by the remaining members of the group.
The “Minimum Number”
of shares of the Corporation’s common stock means 3% of the number of outstanding shares of common stock as of the most recent
date for which such amount is given in any filing by the Corporation with the SEC prior to the submission of the Nomination Notice.
For purposes of this Section,
an Eligible Holder “owns” only those outstanding shares of the Corporation as to which the Eligible Holder possesses both:
(i) the
full voting and investment rights pertaining to the shares; and
(ii) the
full economic interest in (including the opportunity for profit and risk of loss on) such shares;
provided that the number of shares
calculated in accordance with clauses (i) and (ii) shall not include (and to the extent any of the following
arrangements have been entered into by Affiliates of the Eligible Holder (or of any Eligible Holder), shall be reduced by) any shares:
(1) sold by such Eligible Holder or any of its Affiliates in any transaction that has not been settled or closed, including any
short sale, (2) borrowed by such Eligible Holder or any of its Affiliates for any purpose or purchased by such Eligible Holder or
any of its Affiliates pursuant to an agreement to resell, or (3) subject to any option, warrant, forward contract, swap, contract
of sale, other derivative or similar agreement entered into by such Eligible Holder or any of its Affiliates, whether any such instrument
or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of the Corporation,
in any such case which instrument or agreement has, or is intended to have, the purpose or effect of: (x) reducing in any manner,
to any extent or at any time in the future, such Eligible Holder’s or any of its Affiliates’ full right to vote or direct
the voting of any such shares, and/or (y) hedging, offsetting, or altering to any degree, gain or loss arising from the full economic
ownership of such shares by such Eligible Holder or any of its Affiliates.
An Eligible Holder “owns”
shares held in the name of a nominee or other intermediary so long as the Eligible Holder retains the right to instruct how the shares
are voted with respect to the election of directors and the right to direct the disposition thereof and possesses the full economic interest
in the shares. An Eligible Holder’s ownership of shares shall be deemed to continue during any period in which the Eligible Holder
has delegated any voting power by means of a proxy, power of attorney, or other similar instrument or arrangement which in all such cases
is revocable at any time by the Eligible Holder. An Eligible Holder’s ownership of shares shall be deemed to continue during any
period in which the Eligible Holder has loaned such shares provided that the Eligible Holder has retained the power to recall such loaned
shares on no greater than five (5) Business Days’ notice and has recalled such loaned shares as of the date of the Nomination
Notice and holds such shares through the date of the annual meeting. The terms “owned,” “owning” and other variations
of the word “own” shall have correlative meanings. Whether outstanding shares of the Corporation are “owned”
for these purposes shall be determined by the Board.
(iii) No
person shall be permitted to be in more than one group constituting a Nominating Stockholder (and no shares of common stock may be attributed
to more than one Nominating Stockholder), and if any person appears as a member of more than one group, it shall be deemed to be a member
of the group that has the largest ownership position as reflected in the Nomination Notice.
(D) Nomination
Notice. To nominate a Nominee, the Nominating Stockholder must, for receipt no earlier than 150 calendar days and no later than 120
calendar days before the anniversary of the date that the Corporation mailed its proxy statement for the prior year’s annual meeting
of stockholders, submit to the Secretary of the Corporation at the principal executive office of the Corporation all of the following
information and documents (collectively, the “Nomination Notice”):
(i) a
written notice of the nomination of such Nominee that includes the following additional information, agreements, representations and
warranties by the Nominating Stockholder (including each group member):
(a) the
information required in the case of a nomination of directors pursuant to Section 2.8 and 2.9 of these By-laws;
(b) the
details of any relationship that existed within the past three years and that would have been described pursuant to Item 6(e) of
Schedule 14N (or any successor item) had it existed if a Schedule 14N were submitted as of the date of submission of the Nomination Notice;
(c) a
representation and warranty that the Nominating Stockholder acquired the common stock of the Corporation in the ordinary course of business
and did not acquire, and is not holding, securities of the Corporation for the purpose or with the effect or intent of influencing or
changing control of the Corporation;
(d) a
representation and warranty that the Nominee’s candidacy or, if elected, Board membership would not violate applicable state or
federal law or the rules of any stock exchange on which the Corporation’s securities are traded;
(e) a
representation and warranty that the Nominee: does not have any direct or indirect relationship with the Corporation other than those
relationships that have been deemed categorically immaterial pursuant to the Corporation’s Director Independence Guidelines as
most recently published on its website and otherwise qualifies as independent under the rules of the primary stock exchange on which
the Corporation’s securities are traded; meets the director qualifications set forth in Exhibit A to the Corporation’s
Governance Guidelines; and is not and has not been subject to any event specified in Rule 506(d)(1) of Regulation D (or any
successor rule) under the Securities Act or Item 401(f) of Regulation S-K (or any successor rule) under the Exchange Act, without
reference to whether the event is material to an evaluation of the ability or integrity of the Nominee;
(f) a
representation and warranty that the Nominating Stockholder satisfies the eligibility requirements set forth in Section 2.13(C) and
has provided evidence of ownership to the extent required by Section 2.13(C);
(g) a
representation and warranty that the Nominating Stockholder intends to continue to satisfy the eligibility requirements described in
Section 2.13(C) through the date of the annual meeting and intends (subject to any fiduciary obligations to the contrary,
any contractual delegation of investment discretion to a third-party manager, or any mandatory fund rebalancing required by such stockholder’s
preexisting governing instruments or written investment policies) to continue to hold the Minimum Number of shares for at least one year
following the annual meeting;
(h) details
of any position of the Nominee as an officer or director of any competitor (that is, any entity that produces products or provides services
that compete with or are alternatives to the products produced or services provided by the Corporation or its Affiliates) of the Corporation,
within the three years preceding the submission of the Nomination Notice;
(i) a
representation and warranty that the Nominating Stockholder will not engage in, and has not and will not be a “participant”
in another person’s, “solicitation” within the meaning of Rule 14a-1(l) (without reference to the exception
in Section 14a-(l)(2)(iv)) (or any successor rules) with respect to the annual meeting, other than with respect to the Nominating
Stockholder’s Nominee or any nominee of the Board;
(j) a
representation and warranty that the Nominating Stockholder will not use (or distribute to any stockholder) any form of proxy or proxy
card other than the Corporation’s proxy card;
(k) a
representation and warranty that the Nominating Stockholder has not nominated and will not nominate for election to the Board of Directors
at the annual meeting any person other than the Nominee(s) being nominated pursuant to this Section 2.13.
(l) if
desired, one statement for inclusion in the proxy statement in support of the Nominee’s election to the Board of Directors, provided
that such statement shall not exceed 500 words and shall fully comply with Section 14 of the Exchange Act and the rules and
regulations thereunder, including Rule 14a-9; and
(m) in
the case of a nomination by a group of stockholders that together is an Eligible Holder, the designation by all group members of one
group member that is authorized to act on behalf of all group members with respect to matters relating to the nomination, including withdrawal
of the nomination;
(ii) an
executed agreement, in a form deemed satisfactory by the Board of Directors or its designee, acting in good faith, pursuant to which
the Nominating Stockholder (including each group member) agrees:
(a) to
comply with all applicable laws, rules and regulations in connection with their ownership of securities of the Corporation and the
nomination, solicitation and election;
(b) to
file with the SEC any written solicitation or other communication with the Corporation’s stockholders relating to the annual meeting
at which the Nominee will be nominated or otherwise with respect to one or more of the Corporation’s directors or director nominees
or any Nominee with the SEC, regardless of whether any such filing is required under rule or regulation or whether any exemption
from filing is available for such materials under any rule or regulation;
(c) to
assume all liability stemming from an action, suit or proceeding concerning any actual or alleged legal or regulatory violation arising
out of any communication by the Nominating Stockholder with the Corporation, its stockholders or any other person in connection with
the nomination or election of directors, including, without limitation, the Nomination Notice;
(d) to
indemnify and hold harmless (jointly with all other group members, in the case of a group member) the Corporation and each of its directors,
officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys’ fees) incurred
in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the
Corporation or any of its directors, officers or employees arising out of or relating to the information that the Nominating Stockholder
provided to the Corporation or a failure or alleged failure of the Nominating Stockholder to comply with, or any breach or alleged breach
of, its obligations, agreements or representations under this Section 2.13;
(e) in
the event that any information included in the Nomination Notice, or any other communication by the Nominating Stockholder (including
with respect to any group member), with the Corporation, its stockholders or any other person in connection with the nomination or election
ceases to be true and accurate in all material respects (or due to a subsequent development omits a material fact necessary to make the
statements made not misleading), or that the Nominating Stockholder (including any group member) has failed to continue to satisfy the
eligibility requirements described in Section 2.13 (C), to promptly (and in any event within 48 hours of discovering such
misstatement or omission) notify the Corporation and any other recipient of such communication of the misstatement or omission in such
previously provided information and of the information that is required to correct the misstatement or omission;
(iii) an
executed agreement, in the form deemed satisfactory by the Board of Directors or its designee, acting in good faith, by the Nominee:
(a) to
provide to the Corporation a written questionnaire as required by Section 2.9 of these By-laws and such other information
as the Corporation may reasonably request;
(b) making
the representations required by Section 2.9(C), 2.9(D) and 2.9(E) of these By-laws; and
(c) that
the Nominee is not and will not become a party to any Voting Commitment.
The information and documents
required by this Section 2.13(D) shall be: (i) provided with respect to and executed by each group member, in the
case of information applicable to group members; and (ii) provided with respect to the persons specified in Instruction 1 to Items
6(c) and (d) of Schedule 14N (or any successor item) in the case of a Nominating Stockholder or group member that is an entity.
The Nomination Notice shall be deemed submitted on the date on which all the information and documents referred to in this Section 2.13(D) (other
than such information and documents contemplated to be provided after the date the Nomination Notice is provided) have been delivered
to or, if sent by mail, received by the Secretary of the Corporation. In order to be considered timely, the information and documents
required by this Section 2.13(D) to be provided to the Corporation must be updated and supplemented, if necessary, in
accordance with the requirements to update and supplement a stockholder’s notice for an annual meeting in Section 2.8(A).
For the avoidance of doubt, the requirement to update and supplement such information shall not permit an Eligible Holder or other person
to change or add any proposed Nominee or be deemed to cure any defects or limit the remedies (including without limitation under these
By-laws) available to the Corporation relating to any defect.
(E) Exceptions.
Notwithstanding
anything to the contrary contained in this Section 2.13, the Corporation may omit from its proxy statement any Nominee and
any information concerning such Nominee (including a Nominating Stockholder’s statement in support) and no vote on such Nominee
will occur (notwithstanding that proxies in respect of such vote may have been received by the Corporation), and the Nominating Stockholder
may not, after the last day on which a Nomination Notice would be timely, cure in any way any defect preventing the nomination of the
Nominee, if:
(i) the
Corporation receives a notice pursuant to Section 2.8 of these By-laws that a stockholder intends to nominate a candidate
for director at the annual meeting;
(ii) the
Nominating Stockholder or the designated lead group member, as applicable, or any qualified representative thereof, does not appear at
the meeting of stockholders to present the nomination submitted pursuant to this Section 2.13 or the Nominating Stockholder
withdraws its nomination;
(iii) the
Board of Directors, acting in good faith, determines that such Nominee’s nomination or election to the Board of Directors would
result in the Corporation violating or failing to be in compliance with the Corporation’s By-laws or Certificate of Incorporation
or any applicable law, rule or regulation to which the Corporation is subject, including any rules or regulations of any stock
exchange on which the Corporation’s securities are traded;
(iv) the
Nominee was nominated for election to the Board of Directors pursuant to this Section 2.13 at one of the Corporation’s
two preceding annual meetings of stockholders and either withdrew or became ineligible or received a vote of less than 25% of the shares
of common stock entitled to vote for such Nominee;
(v) the
Nominee has been, within the past three years, an officer or director of a competitor, as defined for purposes of Section 8 of the
Clayton Antitrust Act of 1914, as amended; or
(vi) the
Corporation is notified, or the Board of Directors acting in good faith determines, that a Nominating Stockholder has failed to continue
to satisfy the eligibility requirements described in Section 2.13(C), any of the representations and warranties made in the
Nomination Notice ceases to be true and accurate in a material respect (or omits a material fact necessary to make the statement not
misleading), the Nominee becomes unwilling or unable to serve on the Board of Directors or any material violation or breach occurs of
the obligations, agreements, representations or warranties of the Nominating Stockholder or the Nominee under this Section 2.13;
For purposes of this Section 2.13(E),
clauses (i), (iii), (iv), (v) and to the extent related to a breach or failure by the Nominee,
clause (vi), will result in the exclusion from the proxy statement pursuant to this Section 2.13 of the specific Nominee
to whom the ineligibility applies and the ineligibility of such Nominee to be nominated; provided, however, that clause (ii) and
clause (vi), to the extent related to a Nominating Stockholder, will result in the common stock of the Corporation owned
by such Nominating Stockholder being excluded from the shares of common stock used to satisfy the eligibility requirements in Section 2.13(C) (and
in the case of clause (vi), if as a result the Nomination Notice shall no longer have been filed by an Eligible Holder, the
exclusion from the proxy statement pursuant to this Section 2.13 of all of the applicable stockholder’s Nominees from
the applicable annual meeting of stockholders or, in the case of clause (ii) or in the case of clause (vi) if
the proxy statement has already been filed, the ineligibility of all of such stockholder’s Nominees to be nominated).
(F) For
the avoidance of doubt, the Corporation may solicit against, and include in the proxy statement its own statement relating to, any Nominee.
Notwithstanding anything to the contrary contained in this Section 2.13, the Corporation may omit from its proxy statement,
or may supplement or correct, any information, including all or any portion of the statement in support of the Nominee included in the
Nomination Notice, if the Board of Directors in good faith determines that: such information is not true in all material respects or
omits a material statement necessary to make the statements made not misleading; such information directly or indirectly impugns character,
integrity or personal reputation of, or directly or indirectly makes charges concerning improper, illegal or immoral conduct or associations,
without factual foundation, with respect to, any person; or the inclusion of such information in the proxy statement would otherwise
violate the SEC proxy rules or any other applicable law, rule or regulation.
Article III
BOARD OF DIRECTORS
Section 3.1 General
Powers. The business and affairs of the Corporation shall be managed under the direction of the Board of Directors. In addition to
the powers and authorities by these By-laws expressly conferred upon them, the Board of Directors may exercise all such powers of the
Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these By-laws required
to be exercised or done by the stockholders.
Section 3.2 Number,
Tenure and Qualifications. Subject to the rights of the holders of any series of Preferred Stock to elect directors under specified
circumstances, the number of directors shall be fixed from time to time exclusively pursuant to a resolution adopted by a majority of
the Whole Board. No decrease in the number of authorized directors constituting the Whole Board shall shorten the term of any incumbent
director.
Section 3.3 Classes
of Directors. Subject to the rights of the holders of any series of Preferred Stock to elect directors under specified circumstances,
the directors shall be divided, with respect to the time for which they severally hold office, into three classes, as nearly equal in
number as is reasonably possible. At each annual meeting of stockholders, (a) directors elected to succeed those directors whose
terms then expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their
election, with each director to hold office until such person’s successor shall have been duly elected and qualified, and (b) if
authorized by a resolution of the Board of Directors, directors may be elected to fill any vacancy on the Board of Directors, regardless
of how such vacancy shall have been created.
Section 3.4 Regular
Meetings. A regular meeting of the Board of Directors shall be held without other notice than this By-law immediately after, and
at the same place as, the annual meeting of stockholders. The Board of Directors may, by resolution, provide the time and place for the
holding of additional regular meetings without other notice than such resolution.
Section 3.5 Special
Meetings. Special meetings of the Board of Directors shall be called at the request of the Chair of the Board of Directors, the Chief
Executive Officer or a majority of the Board of Directors then in office. The person or persons authorized to call special meetings of
the Board of Directors may fix the place and time of the meetings.
Section 3.6 Notice.
Notice of any special meeting of directors shall be given to each director at such director’s business or residence in writing
by hand delivery, first-class or overnight mail or courier service, email or orally by telephone. If mailed by first-class mail, such
notice shall be deemed adequately delivered when deposited in the United States mails so addressed, with postage thereon prepaid, at
least five (5) days before such meeting. If by overnight mail or courier service, such notice shall be deemed adequately delivered
when the notice is delivered to the overnight mail or courier service company at least twenty-four (24) hours before such meeting. If
by email, telephone or by hand, such notice shall be deemed adequately delivered when the notice is transmitted at least twelve (12)
hours before such meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Board
of Directors need be specified in the notice of such meeting, except for amendments to these By-laws, as provided under Section 10.1
of these By-laws. A meeting may be held at any time without notice if all the directors are present or if those not present waive
notice of the meeting in accordance with Section 8.4 of these By-laws.
Section 3.7 Action
by Consent of Board of Directors. Any action required or permitted to be taken at any meeting of the Board of Directors or of any
committee thereof may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing
or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of
proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in
electronic form if the minutes are maintained in electronic form.
Section 3.8 Conference
Telephone Meetings. Members of the Board of Directors, or any committee thereof, may participate in a meeting of the Board of Directors
or such committee by means of conference telephone or similar communications equipment by means of which all persons participating in
the meeting can hear each other, and such participation in a meeting shall constitute presence in person at such meeting.
Section 3.9 Quorum.
Subject to Section 3.10 of these By-laws, a whole number of directors equal to at least a majority of the Whole Board shall
constitute a quorum for the transaction of business, but if at any meeting of the Board of Directors there shall be less than a quorum
present, a majority of the directors present may adjourn the meeting from time to time without further notice. The act of the majority
of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. The directors present
at a duly organized meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough directors to
leave less than a quorum.
Section 3.10 Vacancies.
Subject to applicable law and the rights of the holders of any series of Preferred Stock with respect to such series of Preferred Stock,
and unless the Board of Directors otherwise determines, vacancies resulting from death, resignation, retirement, disqualification, removal
from office or other cause, and newly created directorships resulting from any increase in the authorized number of directors, may be
filled only by the affirmative vote of a majority of the remaining directors, though less than a quorum of the Board of Directors, and
in the event that there is only one director remaining in office, by such sole remaining director, and directors so chosen shall hold
office for a term expiring at the annual meeting of stockholders at which the term of office of the class to which they have been appointed
expires and until such director’s successor shall have been duly elected and qualified.
Section 3.11 Removal.
Subject to the rights of the holders of any series of Preferred Stock with respect to such series of Preferred Stock, any director, or
the entire Board of Directors, may be removed from office at any time, but only for cause and only by the affirmative vote of the holders
of a majority of the outstanding shares of Voting Stock, voting together as a single class.
Section 3.12 Records.
The Board of Directors shall cause to be kept a record containing the minutes of the proceedings of the meetings of the Board of Directors
and of the stockholders, appropriate stock books and registers and such books of records and accounts as may be necessary for the proper
conduct of the business of the Corporation.
Article IV
Committees
Section 4.1 Appointment.
A majority of the Board of Directors may create one or more committees and appoint members of the Board of Directors to serve on the
committee or committees. Each committee shall have one or more members, who serve at the pleasure of the Board of Directors. The Board
of Directors shall designate one member of each committee to be chair of the committee. The Board of Directors shall designate a secretary
of each committee who may be, but need not be, a member of the committee or the Board of Directors. Any committee, to the extent permitted
by law and provided in the resolution establishing such committee, shall have and may exercise all the powers and authority of the Board
of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed
to all papers which may require it. Each committee shall keep regular minutes and report to the Board of Directors when required.
Section 4.2 Committee
Meetings. A majority of any committee shall constitute a quorum and the act of the majority of the members of a committee present
at a meeting at which a quorum is present shall be the act of such committee. A committee may act by unanimous consent in writing without
a meeting. Committee meetings may be called by the Chair of the Board of Directors, the chair of the committee, or any two of the committee’s
members. The time and place of committee meetings shall be designated in the notice of such meeting. Notice of each committee meeting
shall be given to each committee member. Each Committee shall keep minutes of its proceedings.
Section 4.3 Executive
Committee. The Board of Directors shall appoint an Executive Committee. A majority of the members of the Executive Committee shall
be selected from those Directors who satisfy the independence requirements of the Corporation’s Corporate Governance Guidelines.
The Executive Committee may exercise, subject to applicable provisions of law, all the powers of the Board of Directors in the management
of the business and affairs of the Corporation when the Board of Directors is not in session.
Section 4.4 Audit
Committee. The Board of Directors shall appoint an Audit Committee. The composition of the members and the duties of such committee
shall be as set forth in the Audit Committee Charter.
Section 4.5 Compensation
Committee. The Board of Directors shall appoint a Compensation Committee. The composition of the members and the duties of such committee
shall be as set forth in the Compensation Committee Charter.
Section 4.6 Nominations
and Governance Committee. The Board of Directors shall appoint a Nominations and Governance Committee. The composition of the members
and the duties of such committee shall be as set forth in the Nominations and Governance Committee Charter.
Section 4.7 Public
Policy and Sustainability Committee. The Board of Directors shall appoint a Public Policy and Sustainability Committee. The composition
of the members and the duties of such committee shall be as set forth in the Public Policy and Sustainability Committee Charter.
Article V
OFFICERS
Section 5.1 Officers.
The officers of the Corporation (“Officers”) shall be the Chair of the Board of Directors, the Chief Executive Officer,
one or more Vice Chairmen, one or more Presidents, one or more Executive, Group or Senior Vice Presidents, one or more Vice Presidents,
a Treasurer, a Secretary, a Controller, a General Counsel and such Assistant Treasurers and Assistant Secretaries as the Board of Directors
may elect or the Chair of the Board of Directors may appoint. Any two offices may be held by the same person.
Section 5.2 Election
and Term of Office. The Board of Directors may elect any Officer. The Chair of the Board of Directors may appoint any Senior Vice
President, Vice President, a Controller, a Treasurer, a Secretary and any Assistant Treasurers and Assistant Secretaries. The
Officers of the Corporation shall be elected or appointed annually. Each year, the Board of Directors shall elect Officers at the first
meeting of the Board of Directors held after the annual meeting of stockholders. If the Board of Directors does not elect Officers at
such meeting, such election shall be held as soon thereafter as conveniently may be. Each year, immediately following the election of
Officers by the Board of Directors or as soon thereafter as conveniently may be, the Chair of the Board of Directors shall appoint such
additional Officers within the scope of the Chair’s authority as the Chair deems necessary or appropriate. Vacancies or new offices
may be filled at any time as set forth in Section 5.4. Each Officer shall hold office until such person’s successor
shall have been duly elected or appointed and shall have qualified or until such person’s death or until such person shall resign
or shall have been removed in the manner hereinafter provided.
Section 5.3 Removal
of Officers. Any Officer may be removed by the Board of Directors whenever in its judgment the best interests of the Corporation
will be served thereby. Any Officer appointed by the Chair of the Board of Directors may be removed by the Chair whenever, in the Chair’s
judgment, the best interests of the Corporation will be served thereby.
Section 5.4 Vacancies.
A vacancy in any office because of death, resignation, removal, disqualification or otherwise, may be filled by the Board of Directors
for the unexpired portion of the term. A vacancy in any office appointed by the Chair of the Board of Directors may be filled by the
Chair of the Board of Directors for the unexpired portion of the term.
Section 5.5 Chair
of the Board of Directors; Chief Executive Officer. The Chair shall preside at all meetings of the Board of Directors and the stockholders.
The Chief Executive Officer shall be responsible for the overall management of the Corporation subject to the direction of the Board
of Directors.
Section 5.6 President.
Each President shall be the Chief Operating Officer of a major area of the Corporation’s activities and shall perform such duties
as may be prescribed by the Board of Directors or the Chief Executive Officer.
Section 5.7 Executive,
Group and Senior Vice Presidents. Each Executive, Group, or Senior Vice President shall be responsible for supervising and coordinating
a major area of the Corporation’s activities subject to the direction of the Chief Executive Officer or a President.
Section 5.8 Vice
Presidents. Each of the Vice Presidents shall be responsible for those activities designated by an Executive, Group, or Senior Vice
President, a President, the Chief Executive Officer, or the Board of Directors.
Section 5.9 Treasurer.
The Treasurer shall administer the investment, financing, insurance and credit activities of the Corporation.
Section 5.10 Secretary.
The Secretary will be the custodian of the corporate records and of the seal of the Corporation, will countersign certificates for shares
of the Corporation, and in general will perform all duties incident to the office of the Secretary. The Secretary shall have the authority
to certify the By-laws, resolutions of the stockholders and the Board of Directors and committees thereof, and other documents of the
Corporation as true and correct copies hereof.
Section 5.11 Controller.
The Controller will conduct the accounting activities of the Corporation, including the maintenance of the Corporation’s general
and supporting ledgers and books of account, operating budgets, and the preparation and consolidation of financial statements.
Section 5.12 General
Counsel. The General Counsel will be the chief consultant of the Corporation on legal matters and will supervise all matters of legal
import concerning the interests of the Corporation.
Section 5.13 Assistant
Treasurer. The Assistant Treasurer shall, in the absence or incapacity of the Treasurer, perform the duties and exercise the powers
of the Treasurer, and shall perform such other duties as shall from time to time be given to him or her by the Treasurer.
Section 5.14 Assistant
Secretary. The Assistant Secretary shall, in the absence or incapacity of the Secretary, perform the duties and exercise the powers
of the Secretary, and shall perform such other duties as shall from time to time be given to him or her by the Secretary. The Assistant
Secretary shall be, with the Secretary, keeper of the books, records, and the seal of the Corporation, and shall have the authority to
certify the By-laws, resolutions and other documents of the Corporation.
Section 5.15 General
Powers of Officers. The Chair of the Board of Directors, the Chief Executive Officer, any President, and any Executive, Group or
Senior Vice President, may sign without countersignature any deeds, mortgages, bonds, contracts, reports to public agencies, or other
instruments whether or not the Board of Directors has expressly authorized execution of such instruments, except in cases where the signing
and execution thereof shall be expressly delegated by the Board of Directors or by these By-laws solely to some other Officer or agent
of the Corporation, or shall be required by law to be otherwise signed or executed. Any other Officer of this Corporation may sign contracts,
reports to public agencies, or other instruments which are in the regular course of business and within the scope of such person’s
authority, except where signing and execution thereof shall be expressly delegated by the Board of Directors or by these By-laws to some
other Officer or agent of the Corporation, or shall be required by law to be otherwise signed or executed.
Article VI
STOCK CERTIFICATES AND TRANSFERS
Section 6.1 Certificated
and Uncertificated Stock; Transfers. The interest of each stockholder of the Corporation may be evidenced by certificates for shares
of stock in such form as the appropriate officers of the Corporation may from time to time prescribe or be uncertificated.
The shares of the stock of the
Corporation shall be transferred on the books of the Corporation, in the case of certificated shares of stock, by the holder thereof
in person or by such person’s attorney duly authorized in writing, upon surrender for cancellation of certificates for at least
the same number of shares, with an assignment and power of transfer endorsed thereon or attached thereto, duly executed, with such proof
of the authenticity of the signature as the Corporation or its agents may reasonably require; and, in the case of uncertificated shares
of stock, upon receipt of proper transfer instructions from the registered holder of the shares or by such person’s attorney duly
authorized in writing, and upon compliance with appropriate procedures for transferring shares in uncertificated form. No transfer of
stock shall be valid as against the Corporation for any purpose until it shall have been entered in the stock records of the Corporation
by an entry showing from and to whom transferred.
The certificates of stock shall
be signed, countersigned and registered in such manner as the Board of Directors may by resolution prescribe, which resolution may permit
all or any of the signatures on such certificates to be in facsimile. In case any officer, transfer agent or registrar who has signed
or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such
certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent or
registrar at the date of issue.
Notwithstanding anything to the
contrary in these By-laws, at all times that the Corporation’s stock is listed on a stock exchange, the shares of the stock of
the Corporation shall comply with all direct registration system eligibility requirements established by such exchange, including any
requirement that shares of the Corporation’s stock be eligible for issue in book-entry form. All issuances and transfers of shares
of the Corporation’s stock shall be entered on the books of the Corporation with all information necessary to comply with such
direct registration system eligibility requirements, including the name and address of the person to whom the shares of stock are issued,
the number of shares of stock issued and the date of issue. The Board of Directors shall have the power and authority to make such rules and
regulations as it may deem necessary or proper concerning the issue, transfer and registration of shares of stock of the Corporation
in both the certificated and uncertificated form.
Section 6.2 Lost,
Stolen or Destroyed Certificates. No certificate for shares of stock in the Corporation shall be issued in place of any certificate
alleged to have been lost, destroyed or stolen, except on production of such evidence of such loss, destruction or theft and on delivery
to the Corporation of a bond of indemnity in such amount, upon such terms and secured by such surety, as the Board of Directors or any
financial officer may in its or such person’s discretion require.
Section 6.3 Record
Owners. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares
to receive dividends, and to vote as such owner, and to hold liable for calls and assessments a person registered on its books as the
owner of shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part
of any other person, whether or not it shall have express or other notice thereof, except as otherwise required by law.
Section 6.4 Transfer
and Registry Agents. The Corporation may from time to time maintain one or more transfer offices or agencies and registry offices
or agencies at such place or places as may be determined from time to time by the Board of Directors.
Article VII
INDEMNIFICATION
Section 7.1 Indemnification.
(A) Each
person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (hereinafter a “Proceeding”), by reason of the fact that
such person or a person of whom such person is the legal representative is or was, at any time during which this By-law is in effect
(whether or not such person continues to serve in such capacity at the time any indemnification or advancement of expenses pursuant hereto
is sought or at the time any Proceeding relating thereto exists or is brought), a director or officer of the Corporation or, while a
director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, trustee, employee
or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee
benefit plans maintained or sponsored by the Corporation (hereinafter, a “Covered Person”), whether the basis of such
Proceeding is alleged action in an official capacity as a director or officer or while serving as a director, officer, trustee, employee
or agent, shall be indemnified and held harmless by the Corporation (and any successor of the Corporation by merger or otherwise) to
the fullest extent authorized by the DGCL as the same exists or may hereafter be amended or modified from time to time (but, in the case
of any such amendment or modification, only to the extent that such amendment or modification permits the Corporation to provide greater
indemnification rights than said law permitted the Corporation to provide prior to such amendment or modification), against all expense,
liability and loss (including attorneys’ fees, judgments, fines, excise taxes or penalties (including those arising under the Employee
Retirement Income Security Act of 1974) and amounts paid or to be paid in settlement) actually and reasonably incurred or suffered by
such Covered Person in connection with such Proceeding and such indemnification shall continue as to a person who has ceased to be a
director, officer, trustee, employee or agent and shall inure to the benefit of such person’s heirs, executors and administrators;
provided, however, that except as provided in paragraph (A) of Section 7.3, the Corporation shall
not be required to indemnify any such person (or such person’s heirs, executors or personal or legal representatives) seeking indemnification
in connection with a Proceeding (or part thereof) initiated by such person unless such Proceeding (or part thereof) was authorized or
consented to by the Board of Directors.
(B) To
obtain indemnification under this By-law, a claimant shall submit to the Corporation a written request, including therein or therewith
such documentation and information as is reasonably available to the claimant and is reasonably necessary to determine whether and to
what extent the claimant is entitled to indemnification. Upon written request by a claimant for indemnification, a determination, if
required by applicable law, with respect to the claimant’s entitlement thereto shall be made as follows: (1) if requested
by the claimant, by Independent Counsel (as hereinafter defined), or (2) if no request is made by the claimant for a determination
by Independent Counsel, (i) by the Board of Directors by a majority vote of a quorum consisting of Disinterested Directors (as hereinafter
defined), or (ii) if a quorum of the Board of Directors consisting of Disinterested Directors is not obtainable or, even if obtainable,
such quorum of Disinterested Directors so directs, by Independent Counsel in a written opinion to the Board of Directors, a copy of which
shall be delivered to the claimant, or (iii) if a quorum of Disinterested Directors so directs, by a majority vote of the stockholders
of the Corporation. In the event the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent
Counsel shall be selected by the Board of Directors unless there shall have occurred within two years prior to the date of the commencement
of the Proceeding for which indemnification is claimed a “Change in Control” as defined in the AbbVie 2013 Incentive Stock
Program, in which case the Independent Counsel shall be selected by the claimant unless the claimant shall request that such selection
be made by the Board of Directors. If it is so determined that the claimant is entitled to indemnification, payment to the claimant shall
be made within ten (10) days after such determination.
Section 7.2 Mandatory
Advancement of Expenses. To the fullest extent authorized by the DGCL as the same exists or may hereafter be amended or modified
from time to time (but, in the case of any such amendment or modification, only to the extent that such amendment or modification permits
the Corporation to provide greater rights to advancement of expenses than said law permitted the Corporation to provide prior to such
amendment or modification), each Covered Person shall have (and shall be deemed to have a contractual right to have) the right, without
the need for any action by the Board of Directors, to be paid by the Corporation (and any successor of the Corporation by merger or otherwise)
the expenses incurred in connection with any Proceeding in advance of its final disposition, such advances to be paid by the Corporation
within twenty (20) days after the receipt by the Corporation of a statement or statements from the claimant requesting such advance or
advances from time to time; provided, however, that if the DGCL requires, the payment of such expenses incurred by a director
or officer in such person’s capacity as a director or officer (and not in any other capacity in which service was or is rendered
by such person while a director or officer, including, without limitation, service to an employee benefit plan) shall be made only upon
delivery to the Corporation of an undertaking (hereinafter, the “Undertaking”) by or on behalf of such director or
officer, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further
right of appeal (a “final disposition”) that such director or officer is not entitled to be indemnified for such expenses
under this By-law or otherwise.
Section 7.3 Claims.
(A) (1) If
a claim for indemnification under this Article VII is not paid in full by the Corporation within thirty (30) days after a
written claim pursuant to Section 7.1(B) of these By-laws has been received by the Corporation, or (2) if a request
for advancement of expenses under this Article VII is not paid in full by the Corporation within twenty (20) days after a
statement pursuant to Section 7.2 of these By-laws and the required Undertaking, if any, have been received by the Corporation,
the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim for indemnification
or request for advancement of expenses and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense
of prosecuting such claim. It shall be a defense to any such action that, under the DGCL, the claimant has not met the standard of conduct
which makes it permissible for the Corporation to indemnify the claimant for the amount claimed or that the claimant is not entitled
to the requested advancement of expenses, but (except where the required Undertaking, if any, has not been tendered to the Corporation)
the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its Board of Directors, Independent
Counsel or stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is
proper in the circumstances because such person has met the applicable standard of conduct set forth in the DGCL, nor an actual determination
by the Corporation (including its Board of Directors, Independent Counsel or stockholders) that the claimant has not met such applicable
standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of
conduct.
(B) If
a determination shall have been made pursuant to Section 7.1(B) of these By-laws that the claimant is entitled to indemnification,
the Corporation shall be bound by such determination in any judicial proceeding commenced pursuant to paragraph (A) of this
Section 7.3.
(C) The
Corporation shall be precluded from asserting in any judicial proceeding commenced pursuant to paragraph (A) of this Section 7.3
that the procedures and presumptions of this By-law are not valid, binding and enforceable and shall stipulate in such proceeding
that the Corporation is bound by all the provisions of this By-law.
Section 7.4 Contract
Rights; Amendment and Repeal; Non-exclusivity of Rights.
(A) All
of the rights conferred in this Article VII, as to indemnification, advancement of expenses and otherwise, shall be contract
rights between the Corporation and each Covered Person to whom such rights are extended that vest at the commencement of such Covered
Person’s service to or at the request of the Corporation and (i) any
amendment or modification of this Article VII that in any way diminishes or adversely affects any such rights shall be prospective
only and shall not in any way diminish or adversely affect any such rights with respect to any actual or alleged state of facts, occurrence,
action or omission occurring prior to the time of such amendment or modification, or Proceeding previously or thereafter brought or threatened
based in whole or in part upon any such actual or alleged state of facts, occurrence, action or omission, and (ii) all
of such rights shall continue as to any such Covered Person who has ceased to be a director or officer of the Corporation or ceased to
serve at the Corporation’s request as a director, officer, trustee, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, as described herein, and shall inure to the benefit of such Covered Person’s heirs, executors
and administrators.
(B) All
of the rights conferred in this Article VII, as to indemnification, advancement of expenses and otherwise, (i) shall
not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Certificate of
Incorporation, By-laws, agreement, vote of stockholders or Disinterested Directors or otherwise and (ii) cannot be terminated by
the Corporation, the Board of Directors or the stockholders of the Corporation with respect to a person’s service prior to the
date of such termination.
Section 7.5 Insurance,
Other Indemnification and Advancement of Expenses.
(A) The
Corporation may maintain insurance, at its expense, to protect itself and any current or former director, officer, employee or agent
of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss,
whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.
To the extent that the Corporation maintains any policy or policies providing such insurance, each such current or former director or
officer, and each such agent or employee to which rights to indemnification have been granted as provided in paragraph (B) of
this Section 7.5, shall be covered by such policy or policies in accordance with its or their terms to the maximum extent
of the coverage thereunder for any such current or former director, officer, employee or agent.
(B) The
Corporation may, to the extent authorized from time to time by the Board of Directors or the Chief Executive Officer, grant rights to
indemnification and rights to advancement of expenses incurred in connection with any Proceeding in advance of its final disposition,
to any current or former employee or agent of the Corporation to the fullest extent of the provisions of this By-law with respect to
the indemnification and advancement of expenses of current or former directors and officers of the Corporation.
Section 7.6 Definitions.
For purposes of this By-law:
(A) “Disinterested
Director” means a director of the Corporation who is not and was not a party to the matter in respect of which indemnification
is sought by the claimant.
(B) “Independent
Counsel” means a law firm, a member of a law firm, or an independent practitioner, that is experienced in matters of corporation
law and shall include any person who, under the applicable standards of professional conduct then prevailing, would not have a conflict
of interest in representing either the Corporation or the claimant in an action to determine the claimant’s rights under this By-law.
Section 7.7 Notice.
Any notice, request or other communication required or permitted to be given to the Corporation under this By-law shall be in writing
and either delivered in person or sent by overnight mail, courier service, or certified or registered mail, postage prepaid, return receipt
requested, to the Secretary of the Corporation and shall be effective only upon receipt by the Secretary.
Section 7.8 Severability.
If any provision or provisions of this By-law shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the
validity, legality and enforceability of the remaining provisions of this By-law (including, without limitation, each portion of any
paragraph of this By-law containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid,
illegal or unenforceable) shall not in any way be affected or impaired thereby; and (ii) to
the fullest extent possible, the provisions of this By-law (including, without limitation, each such portion of any paragraph of this
By-law containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent
manifested by the provision held invalid, illegal or unenforceable.
Article VIII
MISCELLANEOUS PROVISIONS
Section 8.1 Fiscal
Year. The fiscal year of the Corporation shall begin on the first day of January and end on the thirty-first day of December of
each year.
Section 8.2 Dividends.
The Board of Directors may from time to time declare, and the Corporation may pay, dividends on its outstanding shares in the manner
and upon the terms and conditions provided by law and the Certificate of Incorporation.
Section 8.3 Seal.
The corporate seal shall have inscribed thereon the words “Corporate Seal”, the year of incorporation and around the margin
thereof the words “AbbVie Inc. - Delaware.”
Section 8.4 Waiver
of Notice. Whenever any notice is required to be given to any stockholder or director of the Corporation under the provisions of
the DGCL or these By-laws, a waiver thereof in writing, signed by the person or persons entitled to such notice, whether before or after
the time stated therein, shall be deemed equivalent to the giving of such notice. Neither the business to be transacted at, nor the purpose
of, any annual or special meeting of the stockholders or the Board of Directors or committee thereof need be specified in any waiver
of notice of such meeting.
Section 8.5 Audits.
The accounts, books and records of the Corporation shall be audited upon the conclusion of each fiscal year by an independent certified
public accountant selected by the Board of Directors, and it shall be the duty of the Board of Directors to cause such audit to be done
annually.
Section 8.6 Resignations.
Except as set forth in Section 2.10(B), any director or any officer, whether elected or appointed, may resign at any time
by giving written notice of such resignation to the Chair of the Board of Directors, the President, or the Secretary, and such resignation
shall be deemed to be effective as of the Close of Business on the date said notice is received by the Chair of the Board of Directors,
the President, or the Secretary, or at such later time as is specified therein. No formal action shall be required of the Board of Directors
or the stockholders to make any such resignation effective.
Article IX
CONTRACTS, PROXIES, ETC.
Section 9.1 Contracts.
Except as otherwise required by law, the Certificate of Incorporation or these By-laws, any contracts or other instruments may be executed
and delivered in the name and on the behalf of the Corporation by such officer or officers of the Corporation as the Board of Directors
may from time to time direct. Such authority may be general or confined to specific instances as the Board of Directors may determine.
The Chair of the Board of Directors, the Chief Executive Officer, any President, and any Executive, Group or Senior Vice President may
execute bonds, contracts, deeds, leases and other instruments to be made or executed for or on behalf of the Corporation. Subject to
any restrictions imposed by the Board of Directors or the Chair of the Board of Directors, the President or any Vice President of the
Corporation may delegate contractual powers to others under such person’s jurisdiction, it being understood, however, that any
such delegation of power shall not relieve such officer of responsibility with respect to the exercise of such delegated power.
Section 9.2 Proxies.
Unless otherwise provided by resolution adopted by the Board of Directors, the Chair of the Board of Directors, the Chief Executive Officer,
a President, an Executive, Group or Senior Vice President may from time to time appoint an attorney or attorneys or agent or agents of
the Corporation, in the name and on behalf of the Corporation, to cast the votes which the Corporation may be entitled to cast as the
holder of stock or other securities in any other corporation, any of whose stock or other securities may be held by the Corporation,
at meetings of the holders of the stock or other securities of such other corporation, or to consent in writing, in the name of the Corporation
as such holder, to any action by such other corporation, and may instruct the person or persons so appointed as to the manner of casting
such votes or giving such consent, and may execute or cause to be executed in the name and on behalf of the Corporation and under its
corporate seal or otherwise, all such written proxies or other instruments as such person may deem necessary or proper in the premises.
Article X
AMENDMENTS
Section 10.1 Amendments.
These By-laws may be altered, amended or repealed, in whole or in part, and new By-laws may be adopted (i) by the affirmative vote
of the shares representing a majority of the votes entitled to be cast by the Voting Stock; provided, however, that
any proposed alteration, amendment or repeal of, or the adoption of any By-law inconsistent with, Section 2.2, 2.12,
3.2, 3.3, 3.10 or 3.11, Article VII or this Article X of these By-laws (in each case,
as in effect on the date hereof), by the stockholders shall require the affirmative vote of shares representing not less than eighty
percent (80%) of the votes entitled to be cast by the Voting Stock; and provided further, however, that in the case
of any such stockholder action at a meeting of stockholders, notice of the proposed alteration, amendment, repeal or adoption of the
new By-law or By-laws must be contained in the notice of such meeting, or (ii) by action of the Board of Directors of the Corporation;
provided, however, that the case of any such action at a meeting of the Board of Directors, notice of the proposed alteration,
amendment, repeal or adoption of the new By-law or By-laws must be given not less than two days prior to the meeting. The provisions
of this Section 10.1 are subject to any provisions requiring a greater vote that are set forth in the Certificate of Incorporation.
v3.24.2.u1
Cover
|
Sep. 06, 2024 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Sep. 06, 2024
|
Current Fiscal Year End Date |
--12-31
|
Entity File Number |
001-35565
|
Entity Registrant Name |
ABBVIE
INC.
|
Entity Central Index Key |
0001551152
|
Entity Tax Identification Number |
32-0375147
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
1
North Waukegan Road
|
Entity Address, City or Town |
North
Chicago
|
Entity Address, State or Province |
IL
|
Entity Address, Postal Zip Code |
60064-6400
|
City Area Code |
847
|
Local Phone Number |
932-7900
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
false
|
Common Stock [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Common
Stock, $0.01 Par Value
|
Trading Symbol |
ABBV
|
Security Exchange Name |
NYSE
|
Common Stock [Member] | NYSE CHICAGO, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Common Stock, $0.01 Par Value
|
Trading Symbol |
ABBV
|
Security Exchange Name |
CHX
|
Senior Notes 0.750 Percent due 2027 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
0.750%
Senior Notes due 2027
|
Trading Symbol |
ABBV27
|
Security Exchange Name |
NYSE
|
Senior Notes 2.125 Percent due 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
2.125%
Senior Notes due 2028
|
Trading Symbol |
ABBV28
|
Security Exchange Name |
NYSE
|
Senior Notes 2.625 Percent due 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
2.625%
Senior Notes due 2028
|
Trading Symbol |
ABBV28B
|
Security Exchange Name |
NYSE
|
Senior Notes 2.125 Percent due 2029 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
2.125%
Senior Notes due 2029
|
Trading Symbol |
ABBV29
|
Security Exchange Name |
NYSE
|
Senior Notes 1.250 Percent due 2031 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
1.250%
Senior Notes due 2031
|
Trading Symbol |
ABBV31
|
Security Exchange Name |
NYSE
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
dei_EntityListingsExchangeAxis=exch_XNYS |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
dei_EntityListingsExchangeAxis=exch_XCHI |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
AbbVie (NYSE:ABBV)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
AbbVie (NYSE:ABBV)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024